Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agent (multiple letters) [1]

Rheumatology

Volumn 40, Issue 9, 2001, Pages 1064-1065

  Filer, A ^a   Hughes, A ^b   Kane, K ^c   Mutimer, D ^b   Jobanputra, P ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; LAMIVUDINE; STEROID; VIRUS ANTIGEN; VIRUS RNA;

ADULT; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS B; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LABORATORY DIAGNOSIS; LETTER; MALE; NONHUMAN; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROGNOSIS; SEROCONVERSION; SKIN BIOPSY; VASCULITIS; VIRUS LOAD; VIRUS REPLICATION;

EID: 0034789592     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/40.9.1064     Document Type: Letter

References (0)